What is the Impact Factor of Journal of Immunotherapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Journal of Immunotherapy is 2.90, ranking in quartile Q3 of Web of Science (SCIE).

Is Journal of Immunotherapy indexed in Web of Science or Scopus?

Yes, Journal of Immunotherapy is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.088 (Q1) and an H-index of 111.

Who publishes Journal of Immunotherapy and what is the Article Processing Charge (APC)?

Journal of Immunotherapy is published by Lippincott Williams and Wilkins Ltd.. The estimated Article Processing Charge (APC) is approximately $3,457 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Journal of Immunotherapy?

The official ISO-4 abbreviation of Journal of Immunotherapy is "J IMMUNOTHER" with common acronym "jit". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q1SCImago #4,255Hybrid

Journal of Immunotherapy

Acronym:jit

•

Abbreviation (ISO):J IMMUNOTHER

•

Identifier (ISSN):1524-9557(Print)/1537-4513(Online)

•

Publisher:Lippincott Williams and Wilkins Ltd.

Official Website Submission Portal Compare

Clarivate IF (2026)

2.9– 0

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Immunotherapy

WoS Q3

Annual Impact Factor Metric

Current (2026):2.9

Scopus SJR & RankScopus Q1

1.088

#4,255

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

111

111 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

52articles/year

25.38% Gold OA•86.27% Original Research

Aims & Scope

Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic. JIT contains full-length articles, review articles, and short communications.

Topics Covered (Recognized by AI)

Medicine96.8%Biology94.1%Genetics90.8%Immunology81.8%Internal medicine78.9%Chemistry69.9%Biochemistry63.2%Immune system61.6%Cancer research52.3%Cancer51.1%Antigen42.8%In vitro42.6%Immunotherapy36.8%Pathology32.2%Cytotoxic T cell31.4%Antibody26.7%Oncology24.4%T cell24.1%Gene24%CD823.1%Surgery20.7%

Primary Research Areas

Medicine Immunology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

IMMUNOLOGY

Rank116/183

IndexSCIE

JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank100/191

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank175/333

IndexSCIE

JCISCIE2026

IMMUNOLOGY

Rank93/183

IndexSCIE

JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank84/191

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank151/333

IndexSCIE

Category	Index	Rank	Quartile
IMMUNOLOGY	JCRSCIE	116/183	Q3
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	100/191	Q3
ONCOLOGY	JCRSCIE	175/333	Q3
IMMUNOLOGY	JCISCIE	93/183	Q3
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	84/191	Q2
ONCOLOGY	JCISCIE	151/333	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.9

Articles / Year22

Total Citations2

2025

IF2.9

Articles / Year46

Total Citations56

2024

IF3.2

Articles / Year48

Total Citations191

2023

IF3.9

Articles / Year51

Total Citations421

2022

IF4.912

Articles / Year41

Total Citations571

Year	Impact Factor	Articles / Year	Total Citations
2026	2.9	22	2
2025	2.9	46	56
2024	3.2	48	191
2023	3.9	51	421
2022	4.912	41	571
2021	4.456	54	846
2020	4.11	47	1,148
2019	3.455	54	1,888
2018	3.826	45	1,572
2017	—	57	2,419
2016	—	45	1,482
2015	—	44	1,731

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,255Scopus Q1SCImago Profile

Scopus Coverage:1991-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.088

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

2.75

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,457 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations426

3-Year Documents145

Citable Documents145

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ1

Cancer ResearchQ2

ImmunologyQ2

Immunology and AllergyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Immunotherapy (acronym: jit, abbr: J IMMUNOTHER, ISSN: 1524-9557) is a peer-reviewed international scholarly journal in the field of Medicine, published by Lippincott Williams and Wilkins Ltd. in United States since 1997. The periodical holds a Journal Impact Factor (JIF) of 2.90, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 1.088 (Q1), an H-index of 111.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 52 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,457 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.